Kellerer, M <br/><br/>
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].  [electronic resource] 

 -  MMW Fortschritte der Medizin  Dec 2003 
 - I-X; quiz XI-XII p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1438-3276 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Deoxynojirimycin--analogs & derivatives<br/>Acarbose--administration & dosage<br/>Aged<br/>Blood Glucose--analysis<br/>Carbamates--administration & dosage<br/>Contraindications<br/>Cyclohexanes--administration & dosage<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Therapy, Combination<br/>Enzyme Inhibitors--administration & dosage<br/>Fasting<br/>Follow-Up Studies<br/>Germany--epidemiology<br/>Glucosamine--administration & dosage<br/>Glyburide--administration & dosage<br/>Glycated Hemoglobin--analysis<br/>Glycoside Hydrolase Inhibitors<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--administration & dosage<br/>Imino Pyranoses<br/>Insulin--administration & dosage<br/>Metformin--administration & dosage<br/>Middle Aged<br/>Nateglinide<br/>Obesity--complications<br/>Patient Compliance<br/>Phenylalanine--administration & dosage<br/>Pioglitazone<br/>Piperidines--administration & dosage<br/>Practice Guidelines as Topic<br/>Risk Factors<br/>Rosiglitazone<br/>Sulfonylurea Compounds--administration & dosage<br/>Thiazolidinediones--administration & dosage<br/>Time Factors